BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7162464)

  • 41. Phase I evaluation of tetrahydrouridine combined with cytosine arabinoside.
    Wong PP; Currie VE; Mackey RW; Krakoff IH; Tan CT; Burchenal JH; Young CW
    Cancer Treat Rep; 1979 Aug; 63(8):1245-9. PubMed ID: 383291
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolism of 4'-thio-beta-D-arabinofuranosylcytosine in CEM cells.
    Parker WB; Shaddix SC; Rose LM; Waud WR; Shewach DS; Tiwari KN; Secrist JA
    Biochem Pharmacol; 2000 Dec; 60(12):1925-32. PubMed ID: 11108809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of the enantioselectivities of human deoxycytidine kinase and human cytidine deaminase.
    Shafiee M; Griffon JF; Gosselin G; Cambi A; Vincenzetti S; Vita A; Eriksson S; Imbach JL; Maury G
    Biochem Pharmacol; 1998 Nov; 56(9):1237-42. PubMed ID: 9802336
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Subcellular distribution of adenosine-, adenosine-5-monophosphate- and cytidine-5-monophosphate desaminase activity in the humna placenta and amnion tissue].
    Zoch E; Häge R
    Zentralbl Gynakol; 1977; 99(6):337-42. PubMed ID: 868358
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytidine deaminase levels in cultured mammalian cell lines measured by the growth tests and enzyme assays.
    Ishii K; Sakamoto H; Furuyama J; Hanaoka M
    Cell Struct Funct; 1984 Jun; 9(2):117-23. PubMed ID: 6498945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determinants in chemosensitivity of oncogene-transformed NIH3T3 cells to 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosylcytosine.
    Zhang M; Endo Y; Sasaki T
    Int J Oncol; 1999 Mar; 14(3):543-9. PubMed ID: 10024689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells.
    Momparler RL; Eliopoulos N; Bovenzi V; Létourneau S; Greenbaum M; Cournoyer D
    Cancer Gene Ther; 1996; 3(5):331-8. PubMed ID: 8894252
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nucleosides. CXIX. Substrate specificity and mechanism of action of cytidine deaminases of monkey plasma and mouse kidney.
    Watanabe KA; Reichman U; Fox JJ; Chou TC
    Chem Biol Interact; 1981 Oct; 37(1-2):41-54. PubMed ID: 7285246
    [No Abstract]   [Full Text] [Related]  

  • 49. Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity.
    Keszler G; Virga S; Spasokoukotskaja T; Bauer PI; Sasvari-Szekely M; Staub M
    Arch Biochem Biophys; 2005 Apr; 436(1):69-77. PubMed ID: 15752710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of cytidine deaminase and tetrahydrouridine interaction by use of ligand techniques.
    Stoller RG; Myers CE; Chabner BA
    Biochem Pharmacol; 1978 Jan; 27(1):53-9. PubMed ID: 619907
    [No Abstract]   [Full Text] [Related]  

  • 51. Ara-C metabolism: implications for drug resistance and drug interactions.
    Chabner BA; Hande KR; Drake JC
    Bull Cancer; 1979; 66(1):89-92. PubMed ID: 420952
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enzymatic studies on possible improvement of cytosine arabinoside treatment.
    Mejer J
    Scand J Clin Lab Invest; 1982 Sep; 42(5):401-6. PubMed ID: 6961505
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Changes in the activities of cytidine deaminase during differentiation of HL60 cells induced by 1,25 dihydroxy D3.
    Mejer J; Mortensen BT
    Leuk Res; 1988; 12(5):405-9. PubMed ID: 3164086
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K; Nayak R; Grant S
    Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transport of two non-metabolized nucleosides, deoxycytidine and cytosine arabinoside, in a sub-line of the L1210 murine leukemia.
    Kessel D; Shurin SB
    Biochim Biophys Acta; 1968 Sep; 163(2):179-87. PubMed ID: 5686275
    [No Abstract]   [Full Text] [Related]  

  • 56. High-performance liquid chromatographic assay for cytosine arabinoside, uracil arabinoside and some related nucleosides.
    Sinkule JA; Evans WE
    J Chromatogr; 1983 May; 274():87-93. PubMed ID: 6575975
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tetrahydrouridine: Physiologic disposition and effect upon deamination of cytosine arabinoside in man.
    Kreis W; Woodcock TM; Gordon CS; Krakoff IH
    Cancer Treat Rep; 1977 Oct; 61(7):1347-53. PubMed ID: 589600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel affinity chromatography method for the co-purification of deoxycytidine kinase and cytidine deaminase.
    Uchida H; Morinaga H; Misaki T; Miyazaki T; Uwajima T; Obata T; Endo Y; Matsuda A; Sasaki T
    Nucleosides Nucleotides Nucleic Acids; 2001 Sep; 20(9):1647-54. PubMed ID: 11580191
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of oestradiol on nucleoside transport in rat uterus.
    Oliver JM
    Biochem J; 1971 Jan; 121(1):83-8. PubMed ID: 5116565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deamination of deoxycytidine nucleotides by the obligate intracytoplasmic bacterium Rickettsia prowazekii.
    Speed RR; Winkler HH
    J Bacteriol; 1991 Aug; 173(15):4902-3. PubMed ID: 1906875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.